Alex

“Gora Kadan” opened “Sushi Kadan” on November 4, 2023

HAKONE, Japan--(BUSINESS WIRE)--Since its establishment in 1952, Gora Kadan has instilled itself as a favorite…

Luxury Carrier STARLUX Airlines Expands US Network; Celebrates Inaugural San Francisco to Taiwan Flight and its Second U.S. Destination

Gate launch event rings in new route to Taipei and onward to 20 Asian destinations…

Propanc Biopharma Engages Boutique Advisory Firm to Identify Strategic Investment Opportunities

MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company…

CrowdStrike and Optiv Surpass $1 Billion in Sales

Premier partnership surpasses key milestone, modernizing and consolidating cybersecurity for thousands of organizations AUSTIN, Texas--(BUSINESS…

AnHeart Therapeutics and Innovent Announce China’s NMPA Has Granted Taletrectinib (ROS1 Inhibitor) Priority Review Designation

NEW YORK & SUZHOU, China--(BUSINESS WIRE)--AnHeart Therapeutics (“AnHeart”), a global clinical-stage biopharmaceutical company developing novel…

Global Subscription Video on Demand (SVOD) Forecasts Report 2023-2029 with Profiles of Netflix, Disney+, Paramount+, HBO Max, Amazon Prime Video and Apple TV+ – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global SVOD Forecasts Update 2029" report has been added to ResearchAndMarkets.com's offering. Global…

Two Phase 3 Trials of Datopotamab Deruxtecan Plus Durvalumab Initiated in Patients Across Two Breast Cancer Subtypes

TROPION-Breast04 is evaluating Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan plus durvalumab as neoadjuvant treatment for…

GTA Announces $200 Million Strategic Investment from Stonepeak

TAMUNING, Guam & NEW YORK--(BUSINESS WIRE)--TeleGuam Holdings, LLC ("GTA"), Guam’s leading digital infrastructure provider of…

Nextick Lightgun from AINEX Surpasses Funding Goal on Indiegogo, Promises to Revolutionize Gaming Experience

SEOUL, South Korea--(BUSINESS WIRE)--#3Dcontroller--AINEX, renowned for pioneering 3D controller development, has completed the funding of…

Azura Ophthalmics Announces Positive Results from Phase 2 Clinical Trial of AZR-MD-001 in Patients with Contact Lens Discomfort

Study met its primary endpoint and showed significant and clinically meaningful improvements in multiple symptoms…